Therapeutic Errors Associated With Antithrombotic Medications Reported to United States Poison Centers
American Journal of Hematology · 2025
DOI: 10.1002/ajh.27595 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hematology, 2025. Verfasst von Emma N Cravo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Injury Research and Policy, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Poison Control Centers, Fibrinolytic Agents, Medication Errors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Child Injury Prevention Alliance.
Abstract (Originalsprache)
The objective of this study was to investigate the characteristics and trends of therapeutic errors in non‐healthcare facility settings associated with antithrombotic medications reported to United States Poison Centers by analyzing data from the National Poison Data System from 2000 to 2021. There were 57 288 reported therapeutic error‐related exposures involving antithrombotic medications as the primary substance. The rate of therapeutic errors increased by 590.9% during this 22‐year period. Although most (90.1%) therapeutic errors were clinically inconsequential and did not receive treatment at a healthcare facility, 2.3% were medically admitted, and 2.1% experienced a serious medical outcome, including 16 fatalities. Three‐fourths (74.9%) of therapeutic errors were among > 59‐year‐olds, and females represented 58.0% of exposures. Warfarin was the most commonly involved antithrombotic medication (37.5%), followed by direct oral anticoagulants (DOACs, 28.7%) and clopidogrel (23.3%). Therapeutic errors involving warfarin were more likely to be associated with a medical admission (odds ratio [OR] = 2.23; 95% confidence interval [CI]: 1.99–2.49) or a serious medical outcome (OR = 2.99; 95% CI: 2.65–3.37), and DOACs were less likely to be associated with a medical admission (OR = 0.53, 95% CI: 0.46–0.61) or a serious medical outcome (OR = 0.45; 95% CI: 0.38–0.53) than therapeutic errors involving other antithrombotic medications. The rate of therapeutic errors involving warfarin significantly increased by 187.0% during 2000–2011, followed by a 57.6% significant decrease during 2011–2021. The rate of therapeutic errors involving DOACs increased significantly by 1118.2% during 2011–2021. The scenario “inadvertently took/given medication twice” accounted for 56.3% of all therapeutic errors. Increased risk reduction efforts are needed to prevent antithrombotic‐related therapeutic errors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Injury Research and Policy, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
- Rocky Vista University College of Osteopathic Medicine, Ivins, Utah, USA.
- Central Ohio Poison Center, Nationwide Children's Hospital, Columbus, Ohio, USA.
- Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA.
- Child Injury Prevention Alliance, Columbus, Ohio, USA.
ORCID-Profile: Gary A Smith
Förderung
- Child Injury Prevention Alliance
Zitieren
APA
Cravo, E. N., Hays, H. L., Badeti, J., Spiller, H. A., Rine, N. I., Zhu, M., & Smith, G. A. (2025). Therapeutic Errors Associated With Antithrombotic Medications Reported to United States Poison Centers. American Journal of Hematology. https://doi.org/10.1002/ajh.27595
Vancouver
Cravo EN, Hays HL, Badeti J, Spiller HA, Rine NI, Zhu M, et al. Therapeutic Errors Associated With Antithrombotic Medications Reported to United States Poison Centers. American Journal of Hematology. 2025. doi:10.1002/ajh.27595
BibTeX
@article{Cravo2025,
author = {Cravo, Emma N and Hays, Hannah L and Badeti, Jaahnavi and Spiller, Henry A and Rine, Natalie I and Zhu, Motao and Smith, Gary A},
title = {Therapeutic Errors Associated With Antithrombotic Medications Reported to United States Poison Centers},
journal = {American Journal of Hematology},
year = {2025},
doi = {10.1002/ajh.27595}
}
EUVIMED